Adero Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $667K | Buy |
3,182
+413
| +15% | +$86.5K | 0.04% | 111 |
|
|
2024
Q4 | $492K | Sell |
2,769
-1,501
| -35% | -$267K | 0.03% | 124 |
|
|
2024
Q3 | $843K | Buy |
4,270
+246
| +6% | +$48.6K | 0.06% | 92 |
|
|
2024
Q2 | $690K | Buy |
4,024
+836
| +26% | +$143K | 0.05% | 101 |
|
|
2024
Q1 | $580K | Buy |
3,188
+254
| +9% | +$46.3K | 0.04% | 104 |
|
|
2023
Q4 | $455K | Sell |
2,934
-484
| -14% | -$75K | 0.04% | 118 |
|
|
2023
Q3 | $509K | Buy |
3,418
+534
| +19% | +$79.6K | 0.05% | 101 |
|
|
2023
Q2 | $389K | Sell |
2,884
-39
| -1% | -$5.25K | 0.04% | 115 |
|
|
2023
Q1 | $466K | Sell |
2,923
-256
| -8% | -$40.8K | 0.05% | 105 |
|
|
2022
Q4 | $514K | Buy |
3,179
+532
| +20% | +$86K | 0.06% | 95 |
|
|
2022
Q3 | $399K | Sell |
2,647
-604
| -19% | -$91K | 0.05% | 101 |
|
|
2022
Q2 | $495K | Sell |
3,251
-32
| -1% | -$4.87K | 0.07% | 88 |
|
|
2022
Q1 | $532K | Sell |
3,283
-716
| -18% | -$116K | 0.08% | 84 |
|
|
2021
Q4 | $541K | Buy |
3,999
+364
| +10% | +$49.2K | 0.09% | 89 |
|
|
2021
Q3 | $392K | Buy |
3,635
+134
| +4% | +$14.5K | 0.07% | 106 |
|
|
2021
Q2 | $394K | Buy |
3,501
+1,473
| +73% | +$166K | 0.09% | 98 |
|
|
2021
Q1 | $219K | Buy |
2,028
+30
| +2% | +$3.24K | 0.1% | 108 |
|
|
2020
Q4 | $214K | Buy |
+1,998
| New | +$214K | 0.18% | 73 |
|